Possible role of cyclooxygenase II in the acquisition of ovarian luteal function in rodents

Biology of Reproduction

Volumn 69, Issue 3, 2003, Pages 835-842

  Sakurai, Toshihiro ^a   Tamura, Kazuhiro ^a   Okamoto, Shiki ^b   Hara, Takahiko ^b   Kogo, Hiroshi ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

Corpus luteum; Corpus luteum function; Female reproductive tract; Ovary; Progesterone

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; CELL ADHESION MOLECULE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GONADOTROPIN; INDOMETACIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROGESTERONE; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS LUTEUM; CORPUS LUTEUM FUNCTION; ENZYME ACTIVITY; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROGESTERONE SYNTHESIS; PSEUDOPREGNANCY; RAT;

ANIMALS; ANTIGENS, CD30; CORPUS LUTEUM; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; FEMALE; GONADOTROPINS; ISOENZYMES; LUTEINIZATION; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; PROGESTERONE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PSEUDOPREGNANCY; RATS; RATS, WISTAR;

ANIMALIA; RODENTIA;

EID: 0042008027     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod.102.010710     Document Type: Article

References (38)

1. Reynolds LP, Grazul-Bilska AT, Redmer DA. Angiogenesis in the corpus luteum, Endocrine 2000; 12:1-9.
2. Smith MF, McIntush EW, Smith GW. Mechanisms associated with corpus luteum development, J Anim Sci 1994; 72:1857-1872.
3. Tamura H, Greenwald GS, Angiogenesis and its hormonal control in the corpus luteum of the pregnant rat. Biol Reprod 1987; 36:1149-1154.
4. Ferrara N, Chen H, Davis-Smyth T, Gerber HP, Nguyen TN, Peers D, Chisholm V, Hillan KJ, Schwall RH. Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nat Med 1998; 4:336-340.
5. Fraser HM, Dickson SE, Lunn SF, Wulff C, Morris KD, Carroll VA, Bicknell R. Suppression of luteal angiogenesis in the primate after neutralization of vascular endothelial growth factor. Endocrinology 2000; 141:995-1000.
6. Gospodarowicz D, Cheng J, Lui GM, Baird A, Esch F, Bohlen P. Corpus luteum angiogenic factor is related to fibroblast growth factor. Endocrinology 1985; 117:2383-2391.
7. Hyder SM, Stancel GM. Regulation of angiogenic growth factors in the female reproductive tract by estrogens and progestins. Mol Endocrinol 1999; 13:806-811.
8. Reynolds LP, Redmer DA, Expression of the angiogenic factors, basic fibroblast growth factor and vascular endothelial growth factor, in the ovary. J Anim Sci 1998; 76:1671-1681.
9. Zimmermann RC, Hartman T, Bohlen P, Suaer MV, Kitajewski J. Pre-ovulatory treatment of mice with anti-VEGF receptor 2 antibody inhibits angiogenesis in corpora lutea, Microvasc Res 2001; 62:15-25.
10. Berisha B, Schams D, Kosmann M, Amselgruber W, Einspanier R. Expression and tissue concentration of vascular endothelial growth factor, its receptors, and localization in the bovine corpus luteum during estrous cycle and pregnancy. Biol Reprod 2000; 63:1106-1114.
11. Wong WY, Richards JS, Evidence for two antigenically distinct molecular weight of prostaglandin H synthase in the rat ovary. Mol Endocrinol 1991; 5:1269-1279.
12. LeMaire WJ, Leidner R, Marsh JM. Pre and post ovulatory changes in the concentration of prostaglandins in rat graafian follicles. Prostaglandins 1975; 9:221-229.
13. Brown CG, Poyser NL. Studies on ovarian prostaglandin production in relation to ovulation in the rat. J Reprod Fertil 1984; 72:407-414.
14. Tamura K, Kogo H. The mode of action of indomethacin, aspirin and melatonin on the blockage of the first ovulation in immature rat pretreated with PMSG. Jpn J Pharmacol 1989; 50:491-494.
15. Frucht J, Zauberman H. Topical indomethacin effect on neovascularisation of the cornea and on prostaglandin E2 levels. Br J Ophthalmol 1984; 68:656-659.
16. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998; 93:705-716.
17. Ziche M, Jones J, Gullino PM. Role of prostaglandin El and copper in angiogenesis. J Natl Cancer Inst 1982; 69:475-482.
18. 2 and angiogenesis. Proc Soc Exp Biol Med 1983; 172:214-218.
19. Smith CJ, Zhang Y, Koboldt CM, Muhammad J, Zweifel BS, Shaffer A, Talley JJ, Masferrer JL, Seibert K, Isakson PC. Pharmacological analysis of cyclooxygenase-I in inflammation. Proc Natl Acad Sci U S A 1998; 95:13313-13318.
20. Masferrer JL, Zweifel BS, Manning PT, Hauser SD, Leahy KM, Smith WG, Isakson PC, Seibert K. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc Natl Acad Sci U S A 1994; 91:3228-3232.
21. Tamura K, Honda H, Mimaki Y, Sashida Y, Kogo H. Inhibitory effect of a new steroidal saponin, OSW-I, on ovarian functions in rats. Br J Pharmacol 1997; 121:1796-1802.
22. Macchiarelli G. The microvasculature of the ovary: a review by SEM of vascular corrosion casts. J Reprod Dev 2000; 46:207-225.
23. Hara T, Nakano Y, Tanaka M, Tamura K, Sekiguchi T, Minehata K, Copeland NG, Jenkins NA, Okabe M, Kogo H, Mukouyama Y, Miyajima A. Identification of podocalyxin-like protein I as a novel cell surface marker for hemangioblasts in the murine aorta-gonad-meso-nephros region. Immunity 1999; 11:567-578.
24. Luborsky JL, Behrman HR. Isolation and functional aspects of free luteal cells. Methods Enzymol 1985; 109:298-316.
25. Lim H, Paria BC, Das SK, Dinchuk JE, Langenbach R, Trzaskos JM. Dey SK. Multiple female reproductive failures in cyclooxygenase-2-deficient mice. Cell 1997; 91:197-208.
26. 2 and interleukin-1β. Endocrinology 1999; 140:2685-2695.
27. Hizaki H, Segi E, Sugimoto Y, Hirose M, Saji T, Ushikubi F, Matsuoka T, Noda Y, Tanaka T, Yoshida N, Narumiya S, Ichikawa A. Abortive expansion of the cumulus and impaired fertility in mice lacking the prostaglandin E receptor subtype EP(2). Proc Natl Acad Sci U S A 1999; 96:10501-10506.
28. Mikuni M, Pall M, Peterson CM, Perterson CA, Hellberg P, Brannstro M, Richards JS, Hedin L. The selective prostaglandin endoperoxide synthase-2 inhibitor, NS-398, reduces prostaglandin production and ovulation in vivo and in vitro in the rat. Biol Reprod 1998; 59:1077-1083.
29. Armstrong DT, Dorrington JH, Robinson J. Effects of indomethacin and aminoglutethimide phosphate in vivo on luteinizing-hormone-induced alterations of cyclic adenosine monophosphate, prostaglandin F, and steroid levels in preovulatory rat ovaries. Can J Biochem 1976; 54:796-802.
30. Ghosh AK, Hirasawa N, Niki H, Ohuchi K. Cyclooxygenase-2-mediated angiogenesis in carrageenin-induced granulation tissue in rats. J Pharmacol Exp Ther 2000; 295:802-809.
31. Majima M, Hayashi I, Muramatsu M, Katada J, Yamashina S, Katori M. Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants. Br J Pharmacol 2000; 130:641-649.
32. Guo JS, Cho CH, Lam Liu ES, Choy HT, Wang JY, Leung Koo MW. Antiangiogenic effect of a highly selective cyclooxygenase-2 inhibitor on gastric ulcer healing in rats. Toxicol Appl Pharmacol 2002; 183: 41-45.
33. Leahy KM, Ornberg RL, Wang Y, Zweifel BS, Koki AT, Masferrer JL. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. Cancer Res 2002; 62:625-631.
34. Jones MK, Wang H, Peskar BM, Levin E, Itani RM, Sarfeh IJ, Tarnawski AS. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med 1999; 5:1418-1423.
35. 2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis. Cancer Res 1999; 59:4574-4577.
36. Murphy JF, Fitzgerald DJ. Vascular endothelial growth factor induces cyclooxygenase-dependent proliferation of endothelial cells via the VEGF-2 receptor. FASEB J 2001; 15:1667-1669.
37. Pai R, Szabo IL, Soreghan BA, Atay S, Kawanaka H, Tarnawski AS. PGE2 stimulate VEGF expression in endothelial cells via ERK2/JNK I signaling pathways. Biochem Biophys Res Commun 2001; 286:923-928.
38. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997; 277:55-60.